Please assess the completion status of the following clinical trial:

Trial Title: Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women aged at least 50 years~* A previous clinical diagnosis of osteoporosis~* At high risk for fracture~* Current therapy for at least 18 months prior to study entry with either raloxifene HCl or alendronate Na~Exclusion Criteria:~* History of metabolic bone disease other than osteoporosis~* History of malignant neoplasm within the last 5 years except for superficial basal cell carcinoma or squamous cell carcinoma

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).